Accent Therapeutics website screenshot

Accent Therapeutics

Accent Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of small-molecule precision cancer therapies that target critical intracellular dependencies spanning multiple types of cancer. Its pipeline is led by ATX-295, a novel KIF18A inhibitor in clinical development, with data presented at AACR and ASCO. Backed by GV, Accent focuses on precision oncology drug discovery and development. The company does not currently publish a public developer API; this profile captures its corporate and web identity in the API Evangelist network.

Accent Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Oncology.

Accent Therapeutics’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
14.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyPharmaceuticalsOncologyPrecision MedicineDrug Discovery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/accent-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Accent Therapeutics Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: accent-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/accent-therapeutics.png
name: Accent Therapeutics
description: Accent Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of small-molecule precision
  cancer therapies that target critical intracellular dependencies spanning multiple types of cancer. Its pipeline is led
  by ATX-295, a novel KIF18A inhibitor in clinical development, with data presented at AACR and ASCO. Backed by GV, Accent
  focuses on precision oncology drug discovery and development. The company does not currently publish a public developer
  API; this profile captures its corporate and web identity in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/accent-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/accent-therapeutics-domain-security.yml
- type: Website
  url: https://accenttx.com
- type: Blog
  url: https://accenttx.com/news-events/
- type: PrivacyPolicy
  url: https://accenttx.com/privacy-policy/
- type: TermsOfService
  url: https://accenttx.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence